| 1. |
Sea M, Ferreira N, Coelho T. Vitreous amyloidosis as the presenting symptom of familial amyloid polyneuropathy TTR Val30Met in a Portuguese patient[J]. Case Rep Ophthalmol, 2014, 5(1): 92-97. DOI: 10.1159/000360790.
|
| 2. |
Planté-Bordeneuve V, Said G. Familial amyloid polyneuropathy[J]. Lancet Neurol, 2011, 10(12): 1086-1097. DOI: 10.1016/S1474-4422(11)70246-0.
|
| 3. |
Beirao JM, Malheiro J, Lemos C, et al. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases[J]. Amyloid, 2015, 22(2): 117-122. DOI: 10.3109/13506129.2015.1015678.
|
| 4. |
Cavallaro T, Martone RL, Dwork AJ, et al. The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye[J]. Invest Ophthalmol Vis Sci, 1990, 31(3): 497-501.
|
| 5. |
Venkatesh P, Selvan H, Singh SB, et al. Vitreous amyloidosis: ocular, systemic, and genetic insight[J]. Ophthalmology, 2017, 124(7): 1014-1022. DOI: 10.1016/j.ophtha.2017.03.011.
|
| 6. |
Liu T, Zhang B, Jin X, et al. Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation[J]. Eye, 2014, 28(1): 26-33. DOI: 10.1038/eye.2013.217.
|
| 7. |
Lv W, Chen J, Chen W, et al. Multimodal retinal imaging in a Chinese kindred with familial amyloid polyneuropathy secondary to transthyretin Ile107Met mutation[J]. Eye, 2014, 28(4): 452-458. DOI: 10.1038/eye.2014.10.
|
